Life sciences real estate advisory for institutional investors
Investment sales advisory for R&D laboratories, biotech campuses, and specialized lab space in innovation clusters and life sciences gateway markets.
Life sciences demand is driven by innovation and funding
U.S. life sciences real estate has experienced significant growth driven by biotechnology innovation, increased NIH funding, and the sector's resilience through economic cycles. R&D laboratories, biotech campuses, and specialized lab space in innovation clusters command premium rents and strong tenant demand. However, rising interest rates and construction costs have introduced new underwriting discipline requirements. Murivest advises on the acquisition and disposition of life sciences real estate across primary and emerging innovation markets.
Key market drivers
- Biotechnology innovation and drug development pipeline growth
- Increased NIH and private R&D funding
- Demand for specialized lab space with high power and HVAC specifications
- Innovation cluster concentration in gateway markets
- Tenant credit quality and lease term length as key value determinants
Advisory scope
- Life sciences lab and R&D facility dispositions
- Biotech campus and research park acquisitions
- Spec lab and build-to-suit disposition advisory
- Capital markets advisory for life sciences financing
- Portfolio transactions across innovation markets
Key life sciences markets
Murivest covers life sciences real estate investment sales across primary and emerging innovation clusters.
Engage Murivest for life sciences real estate advisory
Whether acquiring, disposing, or financing life sciences assets, our team is ready to advise.